Entire Transcript in Adobe Acrobat Format - National Reference ...

17
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
that are collected before we publish the report and before
our recommendations have a chance to get in to effect.
Samples collected in the future would be samples collected
under recommendations that would modify the procedures
currently used. We thought that there were important
reasons to distinguish those two. In part, one does not
want to throw away what we have -- the 200 plus million
samples.
At one point in our deliberations we had
divided samples collected for the purpose of clinical care,
that is you go in for a biopsy for your care, from samples
collected as part of a research study, part of N-HANES, the
Physicians Health Study, the Nurses Health Study, whatever.
In our deliberations we began to see, I think,
that those were not tenable, those distinctions, and that
we should, in fact, collapse them and treat them the same,
that whether the consent procedures were different, and in
many cases they are different, the requirements that we
would want to put into place, in fact, are the same or
similar.
Then we made this distinction between those
samples that are going to be used in an individually
anonymous manner from those to be used so individual
identification is possible. Initially we had the following